← Back to OCUL

Ocular Therapeutix, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 03/08/2026Sep 2025Filed 04/11/2025Jun 2025Filed 03/08/2026Mar 2025Filed 03/08/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$13$11$15$13$11$15$16$15
−$79−$89−$69−$68−$64−$36−$44−$65
−$0.35−$0.40−$0.38−$0.39−$0.38−$0.22−$0.26−$0.49
225224184173169167166132

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.